In addition, MSI2 directly regulates estrogen receptor 1 (ESR1) expression, which is a well-known therapeutic target, by binding to the specific sites in ESR1 RNA and increasing the stability of ESR1 protein, thus affecting the growth of breast cancer cells (47) (Figure 8;Table 2). The gene discussed is ESR1; the disease is breast cancer.